Medical student in the 7th semester at the Faculty of Medicine of the University of São Paulo (FMUSP), with entrance in 2022. Currently works as a research student at the Laboratory of Genetics and Molecular Cardiology (LGCM) in the cardiorenal field, since January 2023, with funding from FAPESP. Presently enrolled in a research exchange at the University of South Florida (USF) in a partner laboratory. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Na+/glucose cotransporter type 2 inhibitors (iSGLT2), also known as gliflozins, confer cardiorenal benefits, the precise mechanisms of which remain incompletely understood. Originally developed for treating type 2 diabetes mellitus (T2D), it was unexpectedly observed that these drugs reduce hospitalizations for heart failure (HF) and mortality from cardiovascular causes, irrespective of a…
| 1 / 1 | Completed scholarships in Brazil |
| Associated processes | |
CV Lattes
ORCID